Investing.com - McKesson (NYSE:MCK) reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
McKesson announced earnings per share of $4.27 on revenue of $58.54B. Analysts polled by Investing.com anticipated EPS of $4.08 on revenue of $55.53B. That with comparison to EPS of $3.69 on revenue of $52.43B in the same period a year before.McKesson had reported EPS of $3.81 on revenue of $59.17B in the previous quarter.Analysts are expecting EPS of $2.98 and revenue of $56.57B in the upcoming quarter.
McKesson shares are up 4% from the beginning of the year and are trading at $144.63 , down-from-52-week-high.They are outperforming the S&P 500 which is down 9.92% year to date.
McKesson follows other major Healthcare sector earnings this month
McKesson's report follows an earnings beat by Pfizer on Tuesday, April 28, 2020, who reported EPS of $0.8 on revenue of $12.03B, compared to forecasts EPS of $0.73 on revenue of $11.81B.
Merck&Co had beat expectations on Tuesday, April 28, 2020 with first quarter EPS of $1.5 on revenue of $12.06B, compared to forecast for EPS of $1.34 on revenue of $11.48B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar